Legal / IP

AstraZenecaBoehringer Ingelheim

Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA

The U.S. Court of Appeals for the Third Circuit ruled against Merck & Co., Inc. (MSD; NYSE: MRK), rejecting the drugmaker's claim that Medicare drug price negotiations violate the First…

WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

Novo Nordisk Sues Eli Lilly Over Alleged False Advertising of Zepbound and Mounjaro in GLP-1 Market

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
AstraZenecaBMS

China Invalidates Heart Failure Patent for Dapagliflozin, Maintains Protection for Kidney Disease Use

GlaxoSmithKlineGSK

GSK Confronted with Whistleblower Allegations Over Zantac and NDMA Link

AstraZenecaAZ

U.S. Judge Dismisses Johnson & Johnson and Bristol-Myers Squibb Lawsuits Against Drug-Pricing Provisions in Inflation Reduction Act

FibroGenKind Pharmaceuticals

Kind Pharmaceuticals Resolves Trade Secrets Dispute with Fibrogen Amid HIF-PHI Pipeline Development

Show More